Bridgeway Capital Management’s Sutro Biopharma STRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.21K | Hold |
12,900
| – | – | ﹤0.01% | 1176 |
|
|
2025
Q1 | $8.39K | Sell |
12,900
-176,800
| -93% | -$115K | ﹤0.01% | 1171 |
|
|
2024
Q4 | $349K | Buy |
189,700
+90,500
| +91% | +$167K | 0.01% | 890 |
|
|
2024
Q3 | $343K | Sell |
99,200
-96,500
| -49% | -$334K | 0.01% | 946 |
|
|
2024
Q2 | $573K | Sell |
195,700
-80,000
| -29% | -$234K | 0.01% | 830 |
|
|
2024
Q1 | $1.56M | Buy |
275,700
+105,500
| +62% | +$596K | 0.03% | 639 |
|
|
2023
Q4 | $730K | Buy |
+170,200
| New | +$730K | 0.02% | 838 |
|
|
2020
Q1 | – | Sell |
-57,200
| Closed | -$629K | – | 1353 |
|
|
2019
Q4 | $629K | Buy |
57,200
+8,400
| +17% | +$92.4K | 0.01% | 884 |
|
|
2019
Q3 | $444K | Hold |
48,800
| – | – | 0.01% | 1002 |
|
|
2019
Q2 | $555K | Buy |
+48,800
| New | +$555K | 0.01% | 945 |
|